Targeting a Retroviral Vector in the Absence of a Known Cell-Targeting Ligand

Human Gene Therapy

Volumn 14, Issue 16, 2003, Pages 1557-1564

  Bupp, Keith ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; LIGAND; RECEPTOR; RETROVIRUS VECTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL GROWTH; CELL TRANSFORMATION; CELL TYPE; CENTRIFUGATION; CONTROLLED STUDY; GENE LIBRARY; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; TARGET CELL;

CELL LINE; GENE TARGETING; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LEUKEMIA VIRUS, FELINE; LIGANDS; PEPTIDE LIBRARY; PLASMIDS; RETROVIRIDAE; VIRAL ENVELOPE PROTEINS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0242382780     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403322495061     Document Type: Article

References (44)

1. ALTSCHUL, S.F., GISH, W., MILLER, W., MYERS, E.W., and LIPMAN, D.J. (1990). Basic local alignment search tool. J. Mol. Biol. 215, 403-410.
2. BENEDICT, C.A., TUN, R.Y.M., RUBINSTEIN, D.B., GUILLAUME, T., CANNON, P.M., and ANDERSON, W.F. (1999). Targeting retroviral vectors to CD34-expressing cells: Binding to CD34 does not catalyze virus-cell fusion. Hum. Gene Ther. 10, 545-557.
3. BOOMER, S., EIDEN, M., BURNS, C.C., and OVERBAUGH, J. (1997). Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition. J. Virol. 71, 8116-8123.
4. BUPP, K., and ROTH, M. (2000). Strategies and mechanisms for retrovirus retargeting. In Viral Vectors: Basic Science and Gene Therapy. A. Cid-Arregui and A. Garcia-Carranca, eds. (Eaton Publishing, Natick, MA) pp. 379-399.
5. BUPP, K., and ROTH, M.J. (2002). Altering retroviral tropism using a random-display envelope library. Mol. Ther. 5, 329-335.
6. CAMPIONE-PICCARDO, J., RAWLS, W.E., and BACHETTI, S. (1979). Selective assay for Herpes simplex viruses expressing thymidine kinase. J. Virol. 31, 281-287.
7. CHESEBRO, B., and WEHRLY, K. (1985). Different murine cell lines manifest unique patterns of interference to superinfection by murine leukemia viruses. Virology 141, 119-129.
8. COSSET, F.-L., MORLING, F.J., TAKEUCHI, Y., WEISS, R.A., COLLINS, M.K.L., and RUSSELL, S.J. (1995a). Retroviral retargeting by envelopes expressing an N-terminal binding domain. J. Virol. 69, 6314-6322.
9. COSSET, F.-L., TAKEUCHI, Y., BATTINI, J.-L., WEISS, R.A., and COLLINS, M.K.L. (1995b). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
10. DACHS, G.U., DOUGHERTY, G.J., STRATFORD, I.J., and CHAPLIN, D.J. (1997). Targeting gene therapy to cancer: A review. Oncol. Res. 9, 313-325.
11. DONOHUE, P.R., HOOVER, E.A., BELTZ, G.A., RIEDEL, N., HIRSCH, V.M., OVERBAUGH, J., and MULLINS, J.I. (1988). Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J. Virol. 62, 722-731.
12. DUBRIDGE, R.B., TANG, P., HSIA, H.C., LEONG, P.-M., MILLER, J.H., and CALOS, M.P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
13. FOUCHIER, R.A.M., MEYER, B.E., SIMON, J.H.M., FISCHER, U., and MALIM, M.H. (1997). HIV-1 infection of non-dividing cells: Evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import. EMBO J. 16, 4531-4539.
14. GALANIS, E., BATEMAN, A., JOHNSON, K., DIAZ, R.M., JAMES, C.D., VILE, R., and RUSSELL, S.J. (2001). Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas. Hum. Gene Ther. 12, 811-821.
15. GRAHAM, F.L., SMILEY, J., RUSSELL, W.C., and NAIRN, R. (1977). Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36, 59-74.
16. HUGHES, B.W., WELLS, A.H., BEBOK, Z., GADI, V.K., GARVER, R.I., PARKER, W.B., and SORSCHER, E.J. (1995). Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res. 55, 3339-3345.
17. HULL, G.W., MCCURDY, M.A., NASU, Y., BANGMA, C.H., YANG, G., SHIMURA, S., LEE, H.M., WANG, J., ALBANI, J., EBARA, S., SATO, T., TIMME, T.L., and THOMPSON, T.L. (2000). Prostate cancer gene therapy: comparison of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene modified, cell-based vaccines. Clin. Cancer Res. 6, 4101-4109.
18. KAVANAUGH, M.P., MILLER, D.G., ZHANG, W., LAW, W., KOZAK, S.L., KABAT, D., and MILLER, A.D. (1994). Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc. Natl. Acad. Sci. U.S.A. 91, 7071-7075.
19. KOENEMAN, K.S., KAO, C., KO, S.-C., YANG, L., WADA, Y., KALLMES, D.F., GILLENWATER, J.Y., ZHAU, H.E., CHUNG, L.W.K., and GARDNER, T.A. (2000). Osteocalcin-directed gene therapy for prostate-cancer bone metastasis. World J. Urol. 18, 102-110.
20. LAVILLETTE, D., RUSSELL, S.J., and COSSET, F.-L. (2001). Retargeting gene delivery using surface-engineered retroviral vector particles. Curr. Opin. Biotechnol. 12, 461-466.
21. LIU, L., ANDERSON, W.F., BEART, R.W., GORDON, E.M., and HALL, F.L. (2000). Incorporation of tumor vasculature targeting motifs into Moloney murine leukemia virus Env escort proteins enhances retrovirus binding and transduction of human endothelial cells. J. Virol. 74, 5320-5328.
22. LYNCH, H.T., and DE LA CHAPELLE, A. (1999). Genetic susceptibility to non-polyposis colorectal cancer. J. Med. Genet. 36, 801-818.
23. MARTIN, F., CHOWDHURY, S., NEIL, S., PHILLIPPS, N., and COLLINS, M.K. (2002). Envelope-targeted retrovirus vectors transduce melanoma xenografts but not spleen or liver. Mol. Ther. 5, 269-274.
24. MARTIN, V., CORTES, M.L., DE FELIPE, P., FARSETTI, A., CALCATERRA, N.B., and IZQUIERDO, M. (2000). Cancer gene therapy by thyroid hormone-mediated expression of toxin genes. Cancer Res. 60, 3218-3224.
25. MORIZONO, K., BRISTOL, G., XIE, Y.-M., KUNG, S.K.-P., and CHEN, I.S.Y. (2001). Antibody-directed targeting of retroviral vectors via cell surface antigens. J. Virol. 75, 8016-8020.
26. OVERBAUGH, J., DONOHUE, P.R., QUACKENBUSH, S.L., HOOVER, E.A., and MULLINS, J.I. (1988). Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science 239, 906-910.
27. PENG, K.-W., MORLING, F.J., COSSET, F.-L., MURPHY, G., and RUSSELL, S.J. (1997). A gene delivery system activatable by disease-associated matrix metalloproteinases. Hum. Gene Ther. 8, 729-738.
28. PEREDO, C., O'REILLY, L., GRAY, K., and ROTH, M.J. (1996). Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins. J. Virol. 70, 3142-3152.
29. PERGOLIZZI, R.G., KREIS, W., ROTTACH, C., SUSIN, M., and BROOME, J.D. (1993). Mutational status of codons 12 and 13 of the N-and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas. Cancer Invest. 11, 25-32.
30. QUIGLEY, J.G., BURNS, C.C., ANDERSON, M.M., LYNCH, E.D., SABO, K.M., OVERBAUGH, J., and ABKOWITZ, J.L. (2000). Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. Blood 95, 1093-1099.
31. REIN, A. (1982). Interference grouping of murine leukemia viruses: A distinct receptor for the MCF-recombinant viruses in mouse cells. Virology 120, 251-257.
32. RHIM, J.S. (1981). Characterization of sarcoma-positive, leukemia-negative (S+L-) human cells induced by the feline leukemia virus pseudotype of Moloney sarcoma virus. Proc. Soc. Exp. Biol. Med. 167, 597-606.
33. RHIM, J.S., CHO, H.Y., and HUEBNER, R.J. (1975). Non-producer human cells induced by murine sarcoma virus. Int. J. Cancer 15, 23-29.
34. RIEDEL, N., HOOVER, E.A., DORNSIFE, R.E., and MULLINS, J.I. (1988). Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc. Natl. Acad. Sci. U.S.A. 85, 2758-2762.
35. SCHNIERLE, B.S., MORITZ, D., JESCHKE, M., and GRONER, B. (1996). Expression of chimeric envelope proteins in helper cell lines and integration into Moloney murine leukemia virus particles. Gene Ther. 3, 334-342.
36. SHIRASAWA, S., FURUSE, M., YOKOYAMA, N., and SASAZUKI, T. (1993). Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260, 85-88.
37. SNITKOVSKY, S., NIEDERMAN, T.M.J., CARTER, B.S., MULLIGAN, R.C., and YOUNG, J.A.T. (2000). A TVA-single chain antibody fusion protein mediates specific targeting of a subgroup A avian leukosis virus vector to cells expressing a tumor-specific form of epidermal growth factor receptor. J. Virol. 74, 9540-9545.
38. TAILOR, C.S., NOURI, A., LEE, C.G., KOZAK, C., and KABAT, D. (1999a). Cloning and characterization of a cell surface receptor for xenotropic and polytropic murine leukemia viruses. Proc. Natl. Acad. Sci. U.S.A. 96, 927-932.
39. TAILOR, C.S., NOURI, A., ZHAO, Y., TAKEUCHI, Y., and KABAT, D. (1999b). A sodium-dependent neutral-amino-acid transporter mediates infections of feline and baboon endogenous retroviruses and simian type D retroviruses. J. Virol. 73, 4470-4474.
40. TAILOR, C.S., WILLETT, B.J., and KABAT, D. (1999c). A putative cell surface receptor for anemia-inducing feline leukemia virus subgroup C is a member of a transporter superfamily. J. Virol. 73, 6500-6505.
41. TAKEUCHI, Y., VILE, R.G., SIMPSON, B., O'HARA, B., COLLINS, M.K.L., and WEISS, R.A. (1992). Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus. J. Virol. 66, 1219-1222.
42. TRAPMAN, J. (2001). Molecular mechanisms of prostate cancer. Eur. J. Cancer 37, S119-123.
43. VAN ZEIJL, M., JOHANN, S.V., CLOSS, E., CUNNINGHAM, J., EDDY, R., SHOWS, T.B., and O'HARA, B. (1994). A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc. Natl. Acad. Sci. U.S.A. 91, 1168-1172.
44. ZHAO, Y., ZHU, L., LEE, S., LI, L., CHANG, E., SOONG, N.-W., DOUER, D., and ANDERSON, W.F. (1999). Identification of the block in targeted retroviral-mediated gene transfer. Proc. Natl. Acad. Sci. U.S.A. 96, 4005-4010.